Having trouble reading this newsletter? Click here to see it in your browser.
You are receiving this newsletter because you signed up from our web site. Click here to unsubscribe.
forward to a friend
13 April 2010
Current Partnering Newsletter

Dealmakers Update - April 2010

Sponsored this month by:

The 2010 BIO International Convention Features the World’s Largest Biotech One-on-One Partnering Event

Join the global event for biotechnology, May 3-6, 2010, at Chicago’s McCormick Place, and more than 15,000 executives, investors, scientists, researchers, policy makers and journalists from around the world for strategic discussions on fresh business solutions and new opportunities in biotech. Get the most return on your investment from the unparalleled partnering opportunities at the BIO Business Forum, where more than 14,000 face-to-face business development meetings and 190 presentations from emerging companies take place. Additionally, 4,000 industry leaders from 1,800 companies across the world will meet to explore licensing and other business development opportunities.
 

Come together with the industry to access the latest innovations, expert knowledge and resources you need to confront the challenges of today and to strengthen your business for tomorrow. Explore collaborations that will help biotech fulfill the promise to heal, fuel and feed the world.

Visit convention.bio.org for details.

 


  • Editor's corner
  • Scorecard update
  • In the news
  • Partnering roundup
  • Best practice
  • Forthcoming events
  • Partnering reports
  • On the move

Editor's corner

It is less than a month until BIO Convention 2010 and arguably the largest partnering event in the business development calendar.

The BIO Convention provides an excellent venue for meeting potential partners from across the world, with upwards of 15,000 delegates.

Currentpartnering will be present at BIO 2010 - if you want to meet with us contact us now.

There are numerous other events coming as well - see our comprehensive event diary to select your key partnering events for 2010.

Due to popular demand you can follow Currentpartnering's daily updates via LinkedIn and Twitter pages - sign up here.

Just published: We have recently updated the following popular report titles:

All for now and enjoy BIO 2010 in Chicago!

-- Steve Poile --


Scorecard update

Updated today - April 13, 2010

Our Scorecard Index provides a simple overview of recent partnering and M&A activity - see it now - Scorecard Index.

Updated monthly - we will be updating our Scorecard Index - tracking partnering and M&A deals announced every month.

In additon, we track the leading deals by value in the current year, plus a compendium of top deals by value since 2000 - view details at Scorecard.

Latest update! Bigpharma partnering activity 2006 to present - view details here
 


In the news

The following are just some of the deals involving bigpharma announced in the last few weeks:

Deals of note so far in April 2010:

  • Axis-Shield in agreement with Abbott for diabetes immunoassay
  • Almac Group partners with Merck KGaA and the MRC to assess markers of response to cetuximab therapy
  • CureDM partners novel diabetes treatment with Sanofi-Aventis
  • Distribution agreement with Boehringer Ingelheim offers Sigma-Aldrich customers expanded biodegradable polylactide polymers for biomaterials research
  • Crucell in collaboration with GlaxoSmithKline on second generation malaria vaccine candidate
  • Warner Chilcott in amendment to Actonel collaboration with Sanofi-Aventis
  • Pfenex in research study with Pfizer
  • AMAG Pharmaceuticals in anemia drug licensing deal with Takeda
  • Astellas obtains China rights to Teijin Pharma's gout treatment
  • Allergan licenses drug for night-time urination from Serenity Pharmaceuticals
  • Swedish Orphan Biovitrum extends Cyanokit cooperation with Merck Serono

Keep posted on the latest deals and alliances with CurrentPartnering's In the news feature.

Signup for our updates via LinkedIn and Twitter.


Partnering roundup

Just some of the articles picked up by Roundup during early April:

  • Working For A Biotech Start-Up
  • Bay St says life sciences fare better in US
  • UK's Vernalis targets acquisitions, in-licensing
  • Novartis and Roche threaten to quit UK
  • Bristol-Myers gives acting CFO permanent job
  • Celgene sees inflammatory drugs driving new growth
  • New approaches to drug development needed

Follow Roundup online here.

Signup for our updates via LinkedIn and Twitter.
 

 


Best practice

Best practise for dealmakers by dealmakers. Current Partnering seeks out the best articles from various sources, to keep you updated on partnering best practice.

Best Partnering Practices - Just Common Sense, Part 3

We have been designing and organising specialised international partnering conferences since 1987 and in these 23 years I have seen several thousand partnering profiles, i.e. the composition with which conference registrants try to attract the interest of other registrants - more


New and updated reports

Recently updated reports:

Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 3rd edition

The Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 3rd edition report provides comprehensive understanding and unprecedented access to the merger and acquisition (M&A) agreements entered into by the worlds leading biopharma companies

More details and order

Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 3rd edition

The Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare companies. Revised and updated 3rd edition.

More details and order

Partnering Agreements with Bigpharma

The definitive guide to bigpharma partnering interests, contacts & agreements

More details and order

Distribution Agreements in Pharma, Biotech and Diagnostics, 2nd edition

Provides comprehensive understanding and unprecedented access to the distribution agreements entered into by the worlds leading pharma, biotech and diagnostics companies

More details and order

New report titles:

CurrentPartnering has published new titles:

Drug Delivery Partnering Agreements in Pharma, Biotech and Diagnostics

Provides comprehensive understanding and unprecedented access to the drug delivery partnering agreements entered into by the worlds leading companies

• Comprehensive directory of drug delivery deals since 2003
• Drug delivery contract documents
• Drug delivery agreement terms
• Drug delivery agreement structure
• Top drug delivery deals by value
• Most active drug delivery dealmakers
• Access links to over 800 actual drug delivery contract agreements

More details and order

Partnering Agreements in Diagnostics

Providing detailed understanding and analysis of how and why companies enter diagnostic partnering deals, plus access to actual diagnostic agreements
• Comprehensive directory of diagnostic deals since 2003
• Diagnostic contract documents
• Diagnostic agreement terms
• Diagnostic agreement structure
• Top diagnostic deals by value
• Most active diagnostic dealmakers

More details and order

Oncology Partnering Agreements in Pharma, Biotech and Diagnostics

The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies

• Comprehensive directory of oncology deals since 2003
• Oncology contract documents
• Oncology agreement terms
• Oncology agreement structure
• Top oncology deals by value
• Most active oncology dealmakers

More details and order

Option & Evaluation Agreements in Pharma and Biotech

The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies

More details and order

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

The Royalty Financing Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

More details and order


Forthcoming partnering events

Here are some of our suggested events for summer/fall 2010:

MedTech Investing Europe 2010

Paris, France - April 29-30, 2010 - more details

BIO International Convention 2010

Chicago, IL, USA - May 3-6, 2010 - more details

Annual C21 Bioventures 2010

Napa, CA, USA - May 25-27, 2010 - more details

EuroMedtech 2010

Leipzig, Germany - June 1-2, 2010 - more details

BioPartnering India 2010

Bangalore, India - June 2-4, 2010 - more details

ERBI Conference 2010

Cambridge, United Kingdom - June 2-3, 2010 - more details

EuroPLX 43 Berlin

Berlin, Germany - June 14-15, 2010 - more details

Euro-Biotech Forum 2010

Paris, France - June 28-30, 2010 - more details

BioPharm America 2010

Boston, MA, USA - September 15-17, 2010 - more details

View our full events calendar
 


People on the move

The following people have been reported on the move during April 2010:

Scott Tarrant, Peter Ciano, Sam Backenroth to name just a few

read more about the latest people on the move.

If you have news about a business development executive who is on the move - let us know
 


Partnering resources

Current Partnering maintains and regularly updates this list of useful resources for dealmakers across all industries.

The following topic areas are available - updated regularly:

• Partnering organizations
• Financing organizations
• Online Partnering
• Weblogs
• Mentoring/Networking
• Checklists
• Quotes
• Software Tools
• Library
• Journals
• Careers
• Training/education
• Other useful links

Missing something? Let us know and we will include all appropriate resources.
 


Contact us

Steve Poile, Editor

Web: http://www.CurrentPartnering.com

Mail: CurrentPartnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom

Tel: +44 7896 656732

Fax: +44 8703 305993

Email
 


Advertizing and sponsorship

CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.

or contact us to discuss your requirements.
 


About Currentpartnering

CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers

• Reports
• Articles
• In the news
• Networks
• Scorecard
• Events
• On the move
• Careers
• Glossary
• Resources
• Advisers




Sponsored by:




























CurrentPartnering reports

CurrentPartnering is a leading publisher of partnering business intelligence
Here is what our clients say about our reports:

The information you provide is excellent and we look forward to doing more business with you in the future.

...You have published very timely and interesting materials.... I am excited.... It is an excellent publication and pretty well up to date...

- for a full list of our latest publications visit the website at: www.currentpartnering.com
 



Title

Description





This email was sent to [email address suppressed]
Click here to instantly unsubscribe.

Current Partnering is a registered company in the UK - number 5722617
Registered Office: Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom
Email: info@currentpartnering.com